Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 114

Sort by

Sort Order Select

Journal Articles

New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis

Andreas Reiter, Tracy I. George, Jason Gotlib

Blood (2020) 135 (16): 1365–1376.

https://doi.org/10.1182/blood.2019000932

Published: 2020

Journal Articles

Multi-Lineage Dysplasia Assessment By Immunophenotype in Myeloproliferative Neoplasms (MPN): Correlation with Disease' Variant, Clinical Features and Molecular Genetics

Francesco Mannelli, MD, Sara Bencini, Benedetta Peruzzi, Paola Guglielmelli, MD PhD, Annalisa Pacilli, PhD, Giada Rotunno, PhD, Francesca Gesullo, BSci, Blerina Jance, Marida Bonetti, Roberto Caporale, Francesco Annunziato, PhD, Alessandro M. Vannucchi, MD

Blood (2019) 134 (Supplement_1): 1668.

https://doi.org/10.1182/blood-2019-125843

Published: 2019

Journal Articles

Real-World Application of Molecular Genetic Sequencing in the Management of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: The Wisconsin Experience

Lauren Gabriele Banaszak, MD BS, Erica Reinig, MD, Michael Lasarev, MS, Ryan J. Mattison, MD

Blood (2019) 134 (Supplement_1): 2146.

https://doi.org/10.1182/blood-2019-123676

Published: 2019

Journal Articles

Molecular Genetics and Prognosis in Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Daniel Helbig, MD, Ghaith Abu Zeinah, MD, Erica B Bhavsar, BS, Richard R. Furman, MD, John N. Allan, MD

Blood (2019) 134 (Supplement_1): 3025.

https://doi.org/10.1182/blood-2019-125426

Published: 2019

Journal Articles

Coagulation FXIII-a Protein Expression Defines Three Novel Sub-Populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized By Distinct Gene Expression Signatures

Katalin Gyurina, MSc, BSc, Bettina Kárai, MD PhD, Anikó Ujfalusi, MD PhD, Zsuzsanna Hevessy, MD PhD, Gábor Barna, PhD, Pál Jáksó, MD PhD, Gyönygi Pálfi-Mészáros, Szilárd Páliska, PhD, Beáta Scholtz, PhD, János Kappelmayer, MD PhD DSc, Gábor Zahuczky, PhD, Csongor Kiss, MD PhD DSc

Blood (2019) 134 (Supplement_1): 2523.

https://doi.org/10.1182/blood-2019-124333

Published: 2019

Journal Articles

Identification of an Immune Risk Score to Predict the Prognosis of Acute Myeloid Leukemia

Yang Liang, PhD, Yun Wang, Yan-Yu Cai, Siliang Chen, Run-Cong Nie, Zhe-Yuan Qin, PhD, Fang Hu, Weida Wang, MD, Yu-Jun Dai, PhD

Blood (2019) 134 (Supplement_1): 708.

https://doi.org/10.1182/blood-2019-126733

Published: 2019

Journal Articles

Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias

Haya Azouz, Jessica Ternus, Phuong L. Nguyen, MD, Dragan Jevremovic, MD PhD, Mrinal M Patnaik, MDMBBS, Michael M. Timm, Min Shi, MD PhD, Rong He, MD, David S. Viswanatha, Mithun Vinod Shah, MD PhD, Hassan B. Alkhateeb, MD, Naseema Gangat, MBBS, Kebede H. Begna, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Cindy Hengel, Aref Al-Kali, MD

Blood (2019) 134 (Supplement_1): 5406.

https://doi.org/10.1182/blood-2019-125114

Published: 2019

Journal Articles

Detection of Measurable Residual Disease (MRD) in Peripheral Blood: First Report of a Novel Microfluidic Platform in Patients with Acute Myeloid Leukemia (AML)

Matthew C Foster, MD, Yuri Fedoriw, MD, Will Pulley, BA, Joshua Zeidner, MD, Catherine C. Coombs, MD, Emily Mirkin, Maryam Zomorrodi, Rachel Toughiri, PhD, Alena Bartakova, MD, Craig Carson, PhD, Rolf Muller, PhD, Paul M. Armistead, MD PhD

Blood (2019) 134 (Supplement_1): 1417.

https://doi.org/10.1182/blood-2019-127434

Published: 2019

Journal Articles

The molecular genetics of sideroblastic anemia

Sarah Ducamp, Mark D. Fleming

Blood (2019) 133 (1): 59–69.

https://doi.org/10.1182/blood-2018-08-815951

Published: 2019

Journal Articles

Steensma DP. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes. Blood . 2018;132(16):1657-1663.

Blood (2018) 132 (22): 2419.

https://doi.org/10.1182/blood-2018-10-882118

Published: 2018

Journal Articles

The Evolution of Genetic Aberrations in CML Patients Harboring a Ph-Negative Clone: A 6-Year Follow-up Study of 52 Patients

Constance Baer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2018) 132 (Supplement 1): 3002.

https://doi.org/10.1182/blood-2018-99-112061

Published: 2018

Journal Articles

αIIb(R990W), a Gain-of Function Mutation of αIIbβ3, Knock-in Mice Show Moderately Impaired Thrombopoiesis

Keigo Akuta, Kazunobu Kiyomizu, MD, Hirokazu Kashiwagi, Shinji Kunishima, PhD, Fumiaki Banno, Koichi Kokame, Nobuko Nishiura, Hisashi Kato, MD PhD, Shigenori Honda, MD, Yuzuru Kanakura, MD PhD, Toshiyuki Miyata, Yoshiaki Tomiyama, MD

Blood (2018) 132 (Supplement 1): 3743.

https://doi.org/10.1182/blood-2018-99-115953

Published: 2018

Journal Articles

The Molecular Genetic Analysis of Coagulation Factor XI (FXI) Deficiency in Two Chinese Patients

Rong-Fu Zhou, PhD MD, Qian Li, Min Zhou

Blood (2018) 132 (Supplement 1): 5033.

https://doi.org/10.1182/blood-2018-99-118232

Published: 2018

Journal Articles

Two Novel Compound Heterozygous Pathogenic Variants in P2YR12 gene

Arnaud Dupuis, PhD, Doris Böckelmann, PhD, Patricia Laeuffer, Katharina Neubauer, PhD, Christian Gachet, MD PhD, Barbara Zieger

Blood (2018) 132 (Supplement 1): 1154.

https://doi.org/10.1182/blood-2018-99-112833

Published: 2018

Journal Articles

Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic

Zuzana Vrzalova, PhD, Hana Jelinkova, Stepan Hrabovsky, Frantisek Folber, MD PhD, Cyril Salek, Jan Horacek, Marketa Zaliova, Jiri Stika, Martina Slavikova, Sarka Pospisilova, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 4090.

https://doi.org/10.1182/blood-2018-99-118308

Published: 2018

Journal Articles

How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes

David P. Steensma

Blood (2018) 132 (16): 1657–1663.

https://doi.org/10.1182/blood-2018-06-860882

Published: 2018

Journal Articles

RUNX1 Mutations in MDS, s-AML and De Novo AML: Differences in Accompanying Cytogenetic and Molecular Genetic Alterations, Clonal Architecture and Outcome

Anna Stengel, PhD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 2683.

https://doi.org/10.1182/blood.V130.Suppl_1.2683.2683

Published: 2017

Journal Articles

GATA2 in Bone Marrow Failure

Steven M. Holland, MD

Blood (2017) 130 (Supplement 1): SCI-23.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-23.SCI-23

Published: 2017

Journal Articles

Understanding the Genome: Professional Guidelines in Clinical Genomic Testing and Interpretation

Elaine Lyon, PhD

Blood (2017) 130 (Supplement 1): SCI-5.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-5.SCI-5

Published: 2017

Journal Articles

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Depict a High Complexity on the Cytogenetic, but Not on the Molecular Genetic Level and Show MYC Mutations As Prognostic Marker

Anna Stengel, PhD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 4001.

https://doi.org/10.1182/blood.V130.Suppl_1.4001.4001

Published: 2017

NARROW

New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis

Multi-Lineage Dysplasia Assessment By Immunophenotype in Myeloproliferative Neoplasms (MPN): Correlation with Disease' Variant, Clinical Features and Molecular Genetics

Real-World Application of Molecular Genetic Sequencing in the Management of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: The Wisconsin Experience

Molecular Genetics and Prognosis in Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Coagulation FXIII-a Protein Expression Defines Three Novel Sub-Populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized By Distinct Gene Expression Signatures

Identification of an Immune Risk Score to Predict the Prognosis of Acute Myeloid Leukemia

Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias

Detection of Measurable Residual Disease (MRD) in Peripheral Blood: First Report of a Novel Microfluidic Platform in Patients with Acute Myeloid Leukemia (AML)

The molecular genetics of sideroblastic anemia

Steensma DP. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes. Blood . 2018;132(16):1657-1663.

The Evolution of Genetic Aberrations in CML Patients Harboring a Ph-Negative Clone: A 6-Year Follow-up Study of 52 Patients

αIIb(R990W), a Gain-of Function Mutation of αIIbβ3, Knock-in Mice Show Moderately Impaired Thrombopoiesis

The Molecular Genetic Analysis of Coagulation Factor XI (FXI) Deficiency in Two Chinese Patients

Two Novel Compound Heterozygous Pathogenic Variants in P2YR12 gene

Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic

How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes

RUNX1 Mutations in MDS, s-AML and De Novo AML: Differences in Accompanying Cytogenetic and Molecular Genetic Alterations, Clonal Architecture and Outcome

GATA2 in Bone Marrow Failure

Understanding the Genome: Professional Guidelines in Clinical Genomic Testing and Interpretation

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Depict a High Complexity on the Cytogenetic, but Not on the Molecular Genetic Level and Show MYC Mutations As Prognostic Marker

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only